Home / Newsroom / News


Columns Layout = 1

Einstein’s Cardio-Oncology Program Recognized as a Center of Excellence

Feb 15 2023

PHILADELPHIA (February 15, 2023) – The Cardio-Oncology Program at Einstein Medical Center Philadelphia – Jefferson Health has been recognized as a Center of Excellence by the International Cardio-Oncology Society (ICOS), reflecting the program’s “exceptionally high concentration of expertise and related resources” which results in “the best patient outcomes possible,” according to ICOS.

"I am thrilled to announce this recognition," said Dr. Sumeet Mainigi, Einstein's Chair of Cardiology. "We are one of three hospitals in the state of Pennsylvania that are recognized by the society."

Cardio-oncology is a rapidly growing field in cardiology that focuses on the detection, monitoring, and treatment of cardiovascular disease occurring as a side effect of cancer treatments. Cancer patients with underlying heart disease, or are at risk of developing cardiotoxicity secondary to their cancer therapy, are treated collaboratively by a multidisciplinary team including medical oncology, radiation oncology, and cardiovascular specialists.

"This is the first time we have received this recognition," said Dr. Raphael Bonita, director of the program. "It signifies our program's dedication and comprehensive approach to providing high-quality care to our patients with heart disease and cancer and those who are at risk for developing cardiotoxicity from their cancer treatments."

The cardio-oncology program evaluates patients before, during and after the completion of cancer therapy to monitor for cardiotoxicity and effectively treat cardiovascular risk factors and manage existing heart disease if present. The team of cardiovascular specialists also continues to follow cancer patients in the years after recovery given the increased risk of cardiovascular disease in cancer survivorship.

Dr. John Leighton, Division Chair, Medical Oncology and Hematology, noted that “The collaboration and communication with the cardio-oncology team has allowed us to treat our patients with the best regimens, while closely monitoring and managing their cardiovascular health, and improving their outcomes.”

Proceeds from the 2019 Harvest Ball enabled Einstein - Jefferson Health to develop the program and designate funding for state-of-the art 3D echocardiography imaging technology to accurately measure heart function, essential in the care of cancer patients undergoing chemotherapy.

“Despite the challenges of COVID, the program grew and blossomed over the last several years under Dr. Bonita’s leadership and has now achieved an international recognition held by only a small number of hospitals,” Dr. Mainigi said.

"We are truly honored that ICOS has officially recognized our cardio-oncology program for the high quality, collaborative care we provide to our patients," Dr. Bonita said. "We strongly believe that our program can play a major role in improving the lives of our patients."


© 2023 Einstein Healthcare Network. All rights reserved.